Nanotherapeutics in cancer vaccination and challenges:
Nanotherapeutics in Cancer Vaccination and Challenges consolidates the current research on cancer nanomedicine and therapeutic cancer vaccination to explore the most effective and promising avenues. The book covers cancer vaccines before exploring nanotherapeutics, DNA and mRNA vaccines in cancer tr...
Gespeichert in:
| Weitere Verfasser: | , , , , |
|---|---|
| Format: | Buch |
| Sprache: | English |
| Veröffentlicht: |
London ; San Diego, CA ; Cambridge, MA
Academic Press, an imprint of Elsevier
[2022]
|
| Schlagworte: | |
| Zusammenfassung: | Nanotherapeutics in Cancer Vaccination and Challenges consolidates the current research on cancer nanomedicine and therapeutic cancer vaccination to explore the most effective and promising avenues. The book covers cancer vaccines before exploring nanotherapeutics, DNA and mRNA vaccines in cancer treatment. Finally, it considers regulatory and industrial perspectives on cancer vaccination and nanotherapeutics. This resource will be useful for pharmaceutical scientists and researchers focused on biomedical engineering, chemical engineering, vaccine development, and cancer immunotherapy, along with advanced students in these subjects.Cancer is arguably the most complex and challenging disease known to mankind. Over the last two-decades, significant advancements have been made in new and novel concepts of cancer nanomedicines. Therapeutic cancer vaccines may be utilized to inhibit further growth of advanced cancers and/or relapsed tumors that are refractory to conventional therapies, such as surgery, radiation therapy and chemotherapy. - Presents the progress made in cancer medicines from conventional to targeted therapy- Covers the present state-of-the-art of cancer nanomedicines and upcoming therapeutic cancer vaccination- Contains a focus on advanced nanomaterials that are utilized for encapsulation of nucleic acid, mRNA, DNA, siRNA |
| Beschreibung: | 1. Cancer vaccines: Past, present and future; 2. Inorganic Nanoparticulate Carriers in management of Cancer: Theranostic and Toxicity Apprehension; 3. Recent developments in cancer vaccines: Where are we?; 4. Application of Nanotechnology assisted devices in cancer treatment; 5. Protein Based Nanocarriers as a Potent Drug Delivery Vehicle for Cancer Therapy; 6. Nanoparticle-based manipulation of antigen-presenting cells for cancer immunotherapy; 7. Nanotechnology-based manipulation of dendritic cells for enhanced immunotherapy strategies; 8. Peptide based anticancer targeted therapeutics: State of the Art; 9. Polyplexes-based delivery systems for cancer vaccine delivery; 10. Lipopolyplexes-based delivery system for cancer vaccine delivery; 11. Inorganic nanoparticulate carriers in cancer vaccination; 12. Functional nanomaterials and nanocomposites in cancer vaccines; 13. DNA vaccines for cancer treatment: Challenges and promises; 14. mRNA-based nanovaccines as newer treatment modalities in cancer; 15. Cancer immunotherapy: Moving forward with peptide T cell vaccines; 16. Product development and scale-up challenges in cancer vaccine development; 17. Regulatory landscape in the approval of cancer vaccines; 18. Cross-Presentation-based Nanovaccine for Cancer Immunotherapy; 19. Immunotherapy based cancer Vaccines: State of the art; 20. Therapeutics peptides in Anticancer therapy; 21. Inorganic Nanoconjugates For Cancer Theragnosis |
| Beschreibung: | xxix, 464 Seiten Illustrationen |
| ISBN: | 9780128236864 |
Internformat
MARC
| LEADER | 00000nam a2200000 c 4500 | ||
|---|---|---|---|
| 001 | BV047900238 | ||
| 003 | DE-604 | ||
| 005 | 20221122 | ||
| 007 | t | ||
| 008 | 220328s2022 a||| |||| 00||| eng d | ||
| 020 | |a 9780128236864 |c pbk. |9 978-0-12-823686-4 | ||
| 035 | |a (OCoLC)1317694179 | ||
| 035 | |a (DE-599)BVBBV047900238 | ||
| 040 | |a DE-604 |b ger |e rda | ||
| 041 | 0 | |a eng | |
| 049 | |a DE-29 |a DE-19 | ||
| 084 | |a VS 9100 |0 (DE-625)147725:253 |2 rvk | ||
| 245 | 1 | 0 | |a Nanotherapeutics in cancer vaccination and challenges |c edited by Mahfoozur Rahman, Sarwar Beg, Waleed H. Almalki, Nabil A. Alhakamy, Hani Choudhry |
| 264 | 1 | |a London ; San Diego, CA ; Cambridge, MA |b Academic Press, an imprint of Elsevier |c [2022] | |
| 264 | 4 | |c © 2022 | |
| 300 | |a xxix, 464 Seiten |b Illustrationen | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b n |2 rdamedia | ||
| 338 | |b nc |2 rdacarrier | ||
| 500 | |a 1. Cancer vaccines: Past, present and future; 2. Inorganic Nanoparticulate Carriers in management of Cancer: Theranostic and Toxicity Apprehension; 3. Recent developments in cancer vaccines: Where are we?; 4. Application of Nanotechnology assisted devices in cancer treatment; 5. Protein Based Nanocarriers as a Potent Drug Delivery Vehicle for Cancer Therapy; 6. Nanoparticle-based manipulation of antigen-presenting cells for cancer immunotherapy; 7. Nanotechnology-based manipulation of dendritic cells for enhanced immunotherapy strategies; 8. Peptide based anticancer targeted therapeutics: State of the Art; 9. Polyplexes-based delivery systems for cancer vaccine delivery; 10. Lipopolyplexes-based delivery system for cancer vaccine delivery; 11. Inorganic nanoparticulate carriers in cancer vaccination; 12. Functional nanomaterials and nanocomposites in cancer vaccines; 13. DNA vaccines for cancer treatment: Challenges and promises; 14. mRNA-based nanovaccines as newer treatment modalities in cancer; 15. Cancer immunotherapy: Moving forward with peptide T cell vaccines; 16. Product development and scale-up challenges in cancer vaccine development; 17. Regulatory landscape in the approval of cancer vaccines; 18. Cross-Presentation-based Nanovaccine for Cancer Immunotherapy; 19. Immunotherapy based cancer Vaccines: State of the art; 20. Therapeutics peptides in Anticancer therapy; 21. Inorganic Nanoconjugates For Cancer Theragnosis | ||
| 520 | |a Nanotherapeutics in Cancer Vaccination and Challenges consolidates the current research on cancer nanomedicine and therapeutic cancer vaccination to explore the most effective and promising avenues. The book covers cancer vaccines before exploring nanotherapeutics, DNA and mRNA vaccines in cancer treatment. Finally, it considers regulatory and industrial perspectives on cancer vaccination and nanotherapeutics. This resource will be useful for pharmaceutical scientists and researchers focused on biomedical engineering, chemical engineering, vaccine development, and cancer immunotherapy, along with advanced students in these subjects.Cancer is arguably the most complex and challenging disease known to mankind. Over the last two-decades, significant advancements have been made in new and novel concepts of cancer nanomedicines. Therapeutic cancer vaccines may be utilized to inhibit further growth of advanced cancers and/or relapsed tumors that are refractory to conventional therapies, such as surgery, radiation therapy and chemotherapy. - Presents the progress made in cancer medicines from conventional to targeted therapy- Covers the present state-of-the-art of cancer nanomedicines and upcoming therapeutic cancer vaccination- Contains a focus on advanced nanomaterials that are utilized for encapsulation of nucleic acid, mRNA, DNA, siRNA | ||
| 653 | 0 | |a Cancer / Vaccination | |
| 653 | 0 | |a Nanomedicine | |
| 655 | 7 | |0 (DE-588)4143413-4 |a Aufsatzsammlung |2 gnd-content | |
| 700 | 1 | |a Rahman, Mahfoozur |d 1984- |0 (DE-588)1214196969 |4 edt | |
| 700 | 1 | |a Beg, Sarwar |d 1987- |0 (DE-588)1186908556 |4 edt | |
| 700 | 1 | |a Almalki, Waleed H. |4 edt | |
| 700 | 1 | |a Alhakamy, Nabil A. |4 edt | |
| 700 | 1 | |a Choudhry, Hani |4 edt | |
| 776 | 0 | 8 | |i Erscheint auch als |n Online-Ausgabe |z 978-0-12-823687-1 |
| 999 | |a oai:aleph.bib-bvb.de:BVB01-033282170 | ||
Datensatz im Suchindex
| _version_ | 1804183511771381760 |
|---|---|
| adam_txt | |
| any_adam_object | |
| any_adam_object_boolean | |
| author2 | Rahman, Mahfoozur 1984- Beg, Sarwar 1987- Almalki, Waleed H. Alhakamy, Nabil A. Choudhry, Hani |
| author2_role | edt edt edt edt edt |
| author2_variant | m r mr s b sb w h a wh wha n a a na naa h c hc |
| author_GND | (DE-588)1214196969 (DE-588)1186908556 |
| author_facet | Rahman, Mahfoozur 1984- Beg, Sarwar 1987- Almalki, Waleed H. Alhakamy, Nabil A. Choudhry, Hani |
| building | Verbundindex |
| bvnumber | BV047900238 |
| classification_rvk | VS 9100 |
| ctrlnum | (OCoLC)1317694179 (DE-599)BVBBV047900238 |
| discipline | Chemie / Pharmazie |
| discipline_str_mv | Chemie / Pharmazie |
| format | Book |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>04187nam a2200397 c 4500</leader><controlfield tag="001">BV047900238</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">20221122 </controlfield><controlfield tag="007">t</controlfield><controlfield tag="008">220328s2022 a||| |||| 00||| eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9780128236864</subfield><subfield code="c">pbk.</subfield><subfield code="9">978-0-12-823686-4</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)1317694179</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV047900238</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rda</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-29</subfield><subfield code="a">DE-19</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">VS 9100</subfield><subfield code="0">(DE-625)147725:253</subfield><subfield code="2">rvk</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Nanotherapeutics in cancer vaccination and challenges</subfield><subfield code="c">edited by Mahfoozur Rahman, Sarwar Beg, Waleed H. Almalki, Nabil A. Alhakamy, Hani Choudhry</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">London ; San Diego, CA ; Cambridge, MA</subfield><subfield code="b">Academic Press, an imprint of Elsevier</subfield><subfield code="c">[2022]</subfield></datafield><datafield tag="264" ind1=" " ind2="4"><subfield code="c">© 2022</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">xxix, 464 Seiten</subfield><subfield code="b">Illustrationen</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">n</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">nc</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">1. Cancer vaccines: Past, present and future; 2. Inorganic Nanoparticulate Carriers in management of Cancer: Theranostic and Toxicity Apprehension; 3. Recent developments in cancer vaccines: Where are we?; 4. Application of Nanotechnology assisted devices in cancer treatment; 5. Protein Based Nanocarriers as a Potent Drug Delivery Vehicle for Cancer Therapy; 6. Nanoparticle-based manipulation of antigen-presenting cells for cancer immunotherapy; 7. Nanotechnology-based manipulation of dendritic cells for enhanced immunotherapy strategies; 8. Peptide based anticancer targeted therapeutics: State of the Art; 9. Polyplexes-based delivery systems for cancer vaccine delivery; 10. Lipopolyplexes-based delivery system for cancer vaccine delivery; 11. Inorganic nanoparticulate carriers in cancer vaccination; 12. Functional nanomaterials and nanocomposites in cancer vaccines; 13. DNA vaccines for cancer treatment: Challenges and promises; 14. mRNA-based nanovaccines as newer treatment modalities in cancer; 15. Cancer immunotherapy: Moving forward with peptide T cell vaccines; 16. Product development and scale-up challenges in cancer vaccine development; 17. Regulatory landscape in the approval of cancer vaccines; 18. Cross-Presentation-based Nanovaccine for Cancer Immunotherapy; 19. Immunotherapy based cancer Vaccines: State of the art; 20. Therapeutics peptides in Anticancer therapy; 21. Inorganic Nanoconjugates For Cancer Theragnosis</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Nanotherapeutics in Cancer Vaccination and Challenges consolidates the current research on cancer nanomedicine and therapeutic cancer vaccination to explore the most effective and promising avenues. The book covers cancer vaccines before exploring nanotherapeutics, DNA and mRNA vaccines in cancer treatment. Finally, it considers regulatory and industrial perspectives on cancer vaccination and nanotherapeutics. This resource will be useful for pharmaceutical scientists and researchers focused on biomedical engineering, chemical engineering, vaccine development, and cancer immunotherapy, along with advanced students in these subjects.Cancer is arguably the most complex and challenging disease known to mankind. Over the last two-decades, significant advancements have been made in new and novel concepts of cancer nanomedicines. Therapeutic cancer vaccines may be utilized to inhibit further growth of advanced cancers and/or relapsed tumors that are refractory to conventional therapies, such as surgery, radiation therapy and chemotherapy. - Presents the progress made in cancer medicines from conventional to targeted therapy- Covers the present state-of-the-art of cancer nanomedicines and upcoming therapeutic cancer vaccination- Contains a focus on advanced nanomaterials that are utilized for encapsulation of nucleic acid, mRNA, DNA, siRNA</subfield></datafield><datafield tag="653" ind1=" " ind2="0"><subfield code="a">Cancer / Vaccination</subfield></datafield><datafield tag="653" ind1=" " ind2="0"><subfield code="a">Nanomedicine</subfield></datafield><datafield tag="655" ind1=" " ind2="7"><subfield code="0">(DE-588)4143413-4</subfield><subfield code="a">Aufsatzsammlung</subfield><subfield code="2">gnd-content</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Rahman, Mahfoozur</subfield><subfield code="d">1984-</subfield><subfield code="0">(DE-588)1214196969</subfield><subfield code="4">edt</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Beg, Sarwar</subfield><subfield code="d">1987-</subfield><subfield code="0">(DE-588)1186908556</subfield><subfield code="4">edt</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Almalki, Waleed H.</subfield><subfield code="4">edt</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Alhakamy, Nabil A.</subfield><subfield code="4">edt</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Choudhry, Hani</subfield><subfield code="4">edt</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Erscheint auch als</subfield><subfield code="n">Online-Ausgabe</subfield><subfield code="z">978-0-12-823687-1</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-033282170</subfield></datafield></record></collection> |
| genre | (DE-588)4143413-4 Aufsatzsammlung gnd-content |
| genre_facet | Aufsatzsammlung |
| id | DE-604.BV047900238 |
| illustrated | Illustrated |
| index_date | 2024-07-03T19:28:40Z |
| indexdate | 2024-07-10T09:24:37Z |
| institution | BVB |
| isbn | 9780128236864 |
| language | English |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-033282170 |
| oclc_num | 1317694179 |
| open_access_boolean | |
| owner | DE-29 DE-19 DE-BY-UBM |
| owner_facet | DE-29 DE-19 DE-BY-UBM |
| physical | xxix, 464 Seiten Illustrationen |
| publishDate | 2022 |
| publishDateSearch | 2022 |
| publishDateSort | 2022 |
| publisher | Academic Press, an imprint of Elsevier |
| record_format | marc |
| spelling | Nanotherapeutics in cancer vaccination and challenges edited by Mahfoozur Rahman, Sarwar Beg, Waleed H. Almalki, Nabil A. Alhakamy, Hani Choudhry London ; San Diego, CA ; Cambridge, MA Academic Press, an imprint of Elsevier [2022] © 2022 xxix, 464 Seiten Illustrationen txt rdacontent n rdamedia nc rdacarrier 1. Cancer vaccines: Past, present and future; 2. Inorganic Nanoparticulate Carriers in management of Cancer: Theranostic and Toxicity Apprehension; 3. Recent developments in cancer vaccines: Where are we?; 4. Application of Nanotechnology assisted devices in cancer treatment; 5. Protein Based Nanocarriers as a Potent Drug Delivery Vehicle for Cancer Therapy; 6. Nanoparticle-based manipulation of antigen-presenting cells for cancer immunotherapy; 7. Nanotechnology-based manipulation of dendritic cells for enhanced immunotherapy strategies; 8. Peptide based anticancer targeted therapeutics: State of the Art; 9. Polyplexes-based delivery systems for cancer vaccine delivery; 10. Lipopolyplexes-based delivery system for cancer vaccine delivery; 11. Inorganic nanoparticulate carriers in cancer vaccination; 12. Functional nanomaterials and nanocomposites in cancer vaccines; 13. DNA vaccines for cancer treatment: Challenges and promises; 14. mRNA-based nanovaccines as newer treatment modalities in cancer; 15. Cancer immunotherapy: Moving forward with peptide T cell vaccines; 16. Product development and scale-up challenges in cancer vaccine development; 17. Regulatory landscape in the approval of cancer vaccines; 18. Cross-Presentation-based Nanovaccine for Cancer Immunotherapy; 19. Immunotherapy based cancer Vaccines: State of the art; 20. Therapeutics peptides in Anticancer therapy; 21. Inorganic Nanoconjugates For Cancer Theragnosis Nanotherapeutics in Cancer Vaccination and Challenges consolidates the current research on cancer nanomedicine and therapeutic cancer vaccination to explore the most effective and promising avenues. The book covers cancer vaccines before exploring nanotherapeutics, DNA and mRNA vaccines in cancer treatment. Finally, it considers regulatory and industrial perspectives on cancer vaccination and nanotherapeutics. This resource will be useful for pharmaceutical scientists and researchers focused on biomedical engineering, chemical engineering, vaccine development, and cancer immunotherapy, along with advanced students in these subjects.Cancer is arguably the most complex and challenging disease known to mankind. Over the last two-decades, significant advancements have been made in new and novel concepts of cancer nanomedicines. Therapeutic cancer vaccines may be utilized to inhibit further growth of advanced cancers and/or relapsed tumors that are refractory to conventional therapies, such as surgery, radiation therapy and chemotherapy. - Presents the progress made in cancer medicines from conventional to targeted therapy- Covers the present state-of-the-art of cancer nanomedicines and upcoming therapeutic cancer vaccination- Contains a focus on advanced nanomaterials that are utilized for encapsulation of nucleic acid, mRNA, DNA, siRNA Cancer / Vaccination Nanomedicine (DE-588)4143413-4 Aufsatzsammlung gnd-content Rahman, Mahfoozur 1984- (DE-588)1214196969 edt Beg, Sarwar 1987- (DE-588)1186908556 edt Almalki, Waleed H. edt Alhakamy, Nabil A. edt Choudhry, Hani edt Erscheint auch als Online-Ausgabe 978-0-12-823687-1 |
| spellingShingle | Nanotherapeutics in cancer vaccination and challenges |
| subject_GND | (DE-588)4143413-4 |
| title | Nanotherapeutics in cancer vaccination and challenges |
| title_auth | Nanotherapeutics in cancer vaccination and challenges |
| title_exact_search | Nanotherapeutics in cancer vaccination and challenges |
| title_exact_search_txtP | Nanotherapeutics in cancer vaccination and challenges |
| title_full | Nanotherapeutics in cancer vaccination and challenges edited by Mahfoozur Rahman, Sarwar Beg, Waleed H. Almalki, Nabil A. Alhakamy, Hani Choudhry |
| title_fullStr | Nanotherapeutics in cancer vaccination and challenges edited by Mahfoozur Rahman, Sarwar Beg, Waleed H. Almalki, Nabil A. Alhakamy, Hani Choudhry |
| title_full_unstemmed | Nanotherapeutics in cancer vaccination and challenges edited by Mahfoozur Rahman, Sarwar Beg, Waleed H. Almalki, Nabil A. Alhakamy, Hani Choudhry |
| title_short | Nanotherapeutics in cancer vaccination and challenges |
| title_sort | nanotherapeutics in cancer vaccination and challenges |
| topic_facet | Aufsatzsammlung |
| work_keys_str_mv | AT rahmanmahfoozur nanotherapeuticsincancervaccinationandchallenges AT begsarwar nanotherapeuticsincancervaccinationandchallenges AT almalkiwaleedh nanotherapeuticsincancervaccinationandchallenges AT alhakamynabila nanotherapeuticsincancervaccinationandchallenges AT choudhryhani nanotherapeuticsincancervaccinationandchallenges |